Summary
Updated Aug 30, 2026
John C. McKew is Chief Scientific Officer of LUMOS PHARMA, INC. (LUMO). 1 SEC Form 4 filing on record, dated 13 December 2024.
Recent Transactions
1Every recent SEC Form 4 transaction John C. McKew has reported, most recent first.
Most Active Insiders Right Now
John C. McKew has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- SL SPV-2, L.P. - $341.29M of DELL open-market activity in the last 90 days
- Silver Lake Partners IV, L.P. - $319.53M of DELL open-market activity in the last 90 days
- BAKER BROS. ADVISORS LP - $317.75M of CELC open-market activity in the last 90 days
- Martine A. Rothblatt - $304.24M of UTHR open-market activity in the last 90 days
- Fairmount Funds Management LLC - $300.01M of ORKA open-market activity in the last 90 days
- Chitung Liu - $294.29M of UMC open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is John C. McKew?
John C. McKew is a corporate insider, tracked as Chief Scientific Officer of LUMOS PHARMA, INC. (LUMO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did John C. McKew last file a Form 4?
The only primary Form 4 on record is dated 13 December 2024.
Where can I see all of John C. McKew's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow John C. McKew and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
